Vertex Innovation Awards
The Vertex Innovation Awards support cutting-edge clinical research to improve cystic fibrosis care, with a focus on CFTR modulators and impactful studies by established CF researchers.
Funder: Vertex Pharmaceuticals
Due Dates (Anticipated): October 2026 (full application deadline)
Funding Amounts: Up to $750,000 USD per project; up to four projects funded annually.
Summary: Supports innovative and collaborative clinical research projects to improve care for people with cystic fibrosis (CF).
Key Information: Highly competitive; for established CF researchers; independent review committee.
Description
The Vertex Innovation Awards (VIA) are designed to fund innovative, collaborative clinical research projects that advance the care and understanding of cystic fibrosis (CF). Each year, up to four projects are selected by an independent committee of external experts, with each project eligible for up to $750,000 USD in funding. The program specifically seeks proposals from established researchers in the CF field, aiming to support groundbreaking clinical studies that can lead to meaningful improvements in CF patient outcomes.
